Yoshio Imai
- Pharmacology top 0.02%
- Molecular Biology top 5%
- Oncology top 2%
- Biochemistry top 0.5%
- Clinical Biochemistry top 0.5%
- Co-authors
- Ryo SatoAkio ItoNozomu OshinoHisaaki TaniguchiChikako HashimotoMasa‐aki KakimotoTakashi IyanagiTsutomu Shimada
- Topics
- Pharmacogenetics and Drug Metabolism (33 papers)Metabolomics and Mass Spectrometry Studies (13 papers)Metabolism and Genetic Disorders (12 papers)
- Partner nations
- JapanUnited States
In The Last Decade
Yoshio Imai
105 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Pharmacology 2.7k
- Molecular Biology 2.0k
- Oncology 1.1k
- Biochemistry 667
- Clinical Biochemistry 451
Countries citing papers authored by Yoshio Imai
This map shows the geographic impact of Yoshio Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshio Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshio Imai more than expected).
Fields of papers citing papers by Yoshio Imai
This network shows the impact of papers produced by Yoshio Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshio Imai. The network helps show where Yoshio Imai may publish in the future.
Co-authorship network of co-authors of Yoshio Imai
This figure shows the co-authorship network connecting the top 25 collaborators of Yoshio Imai. A scholar is included among the top collaborators of Yoshio Imai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshio Imai. Yoshio Imai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 21 | |
| 3 | 11 | |
| 4 | 120 | |
| 5 | 37 | |
| 6 | 50 | |
| 7 | 9 | |
| 8 | 22 | |
| 9 | 35 | |
| 10 | 23 | |
| 11 | 24 | |
| 12 | 31 | |
| 13 | 0 | |
| 14 | Hypotensive Effect of N-Ethoxycarbonyl-3-morpholinosydnonimine(SIN-10) in Carbon Tetrachloride-Treated Rats | 7 |
| 15 | 2 | |
| 16 | Biological studies of AT-308-3-Fffect of AT-308,a new derivative of 1,2,4-oxadiazole,on atherosclerosis in cholesterol-fed rabbits | 1 |
| 17 | 7 | |
| 18 | 7 | |
| 19 | 2 | |
| 20 | 4 |
About Yoshio Imai
Yoshio Imai is a scholar working on Pharmacology, Clinical Biochemistry and Biochemistry, having authored 108 papers that have together received 4.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (33 papers), Metabolomics and Mass Spectrometry Studies (13 papers) and Metabolism and Genetic Disorders (12 papers). The work is most often cited by research in Pharmacology (2.7k citations), Biochemistry (667 citations) and Clinical Biochemistry (451 citations). Yoshio Imai has collaborated with scholars based in Japan and United States. Frequent co-authors include Ryo Sato, Ryo Sato, Ryo Sato, Akio Ito, Nozomu Oshino, Hisaaki Taniguchi, Chikako Hashimoto, Masa‐aki Kakimoto, Takashi Iyanagi and Tsutomu Shimada. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.